179 results on '"Moll, Thomas"'
Search Results
2. Effects of Teriparatide in Patients with Osteoporosis in Clinical Practice: 42-Month Results During and After Discontinuation of Treatment from the European Extended Forsteo® Observational Study (ExFOS)
3. In vitro Degradation of Endothelial Catenins by a Neutrophil Protease
4. Fracture Rate, Quality of Life and Back Pain in Patients with Osteoporosis Treated with Teriparatide: 24-Month Results from the Extended Forsteo Observational Study (ExFOS)
5. A multicenter phase 1/2a dose-escalation study of the antioxidant moiety of vitamin E 2,2,5,7,8-pentamethyl-6-chromanol (APC-100) in men with advanced prostate cancer
6. Reactive Metabolites of 1,3-Butadiene: DNA and Hemoglobin Adduct Formation and Potential Roles in Carcinogenicity
7. The Effect of Teriparatide Treatment on the Risk of Fragility Fractures in Postmenopausal Women with Osteoporosis: Results from the Asian and Latin America Fracture Observational Study (ALAFOS)
8. Protein Import into Mitochondria: ATP-Dependent Protein Translocation Activity in a Submitochondrial Fraction Enriched in Membrane Contact Sites and Specific Proteins
9. Transcription Factors Important for Starting the Cell Cycle in Yeast
10. A Role for the Transcription Factors Mbp1 and Swi4 in Progression from G1 to S Phase
11. The human VE-cadherin promoter is subjected to organ-specific regulation and is activated in tumour angiogenesis
12. Isotype-dependent pathogenicity of autoantibodies: analysis in experimental autoimmune hemolytic anemia
13. An experimental model of cryoglobulin-associated vasculitis in mice
14. Identification of 2 major loci linked to autoimmune hemolytic anemia in NZB mice
15. In vivo over-expression of interleukin-10 increases resistance to focal brain ischemia in mice
16. Expression of aberrant forms of CD22 on B lymphocytes in Cd22a lupus-prone mice affects ligand binding
17. Anti–T-cell Ig and mucin domain–containing protein 1 antibody decreases TH2 airway inflammation in a mouse model of asthma
18. Selective Expansion of a Monocyte Subset Expressing the CD11c Dendritic Cell Marker in the Yaa Model of Systemic Lupus Erythematosus
19. Tuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in hemodialysis patients
20. SENSITIVE IDENTIFICATION OF SPECIFIC T-CELL IMMUNITY TOWARDS M. TUBERCULOSIS IN IMMUNOCOMPROMISED PATIENTS BY THE USE OF A RAPID FLOW-CYTOMETRIC WHOLE-BLOOD ASSAY
21. Differential Control of CD22 Ligand Expression on B and T Lymphocytes, and Enhanced Expression in Murine Systemic Lupus
22. Semisynthetic proteins: model systems for the study of the insertion of hydrophobic peptides into preformed lipid bilayers
23. A central role for SWI6 in modulating cell cycle Start-specific transcription in yeast
24. Study description and baseline characteristics of the population enrolled in a multinational, observational study of teriparatide in postmenopausal women with osteoporosis: the Asia and Latin America Fracture Observational Study (ALAFOS)
25. P-Selectin Glycoprotein Ligand-1 (PSGL-1) on T Helper 1 but Not on T Helper 2 Cells Binds to P-Selectin and Supports Migration into Inflamed Skin
26. ECVAET 3 – The European master craftsperson education and training in event technology: Results and recommendations for a European master craftsperson education and training
27. Human factors study of a newly approved prefilled syringe of epinephrine for the treatment of anaphylaxis
28. Human factors study in untrained adolescents comparing a recently approved single-dose epinephrine prefilled syringe with an approved autoinjector
29. Human Factors Study of a Newly Approved Epinephrine Prefilled syringe (PFS) for the Emergency Treatment of Allergic Reactions (Type I) including Anaphylaxis
30. Conceptual Development and Design of the Turbine Engine Loads Simulator
31. Ueber den Gebrauch Eines Kontext-Spezifischen Helpsystems
32. Electron delocalization in one-electron oxidized aniline oligomers, paradigms for polyaniline. A study by paramagnetic resonance in fluid solution
33. ECVAET 2 - ECVET in Practice in Event Technology Services: Report, Results and Recommendations
34. Phase 1/2a, open-label, dose-escalation and safety study of APC-100 in men with advanced prostate cancer.
35. Ueber den Gebrauch Eines Kontext-Spezifischen Helpsystems
36. DO PEOPLE REALLY USE ON-LINE ASSISTANCE?
37. The role of the 'Yaa (Y-linked autoimmune acceleration)' mutation and the Fc gamma receptor type IIB (FcγRIIB) in the control of lupus-like autoimmune responses in mice
38. Construction and Purification of Adhesion Molecule Immunoglobulin Chimeric Proteins
39. In vivoover-expression of interleukin-10 increases resistance to focal brain ischemia in mice
40. Protection of Murine Systemic Lupus by the Ea Transgene without Expression of I-E Heterodimers
41. Differential engagement of Tim-1 during activation can positively or negatively costimulate T cell expansion and effector function
42. CD8+ T Cells Resistant to Costimulatory Blockade Are Controlled by an Antagonist Interleukin-15/Fc Protein
43. Contribution of NZB Autoimmunity 2 to Y-Linked Autoimmune Acceleration-Induced Monocytosis in Association with Murine Systemic Lupus
44. An Antagonist Mutant IL-15/Fc Promotes Transplant Tolerance
45. Expression of aberrant forms of CD22 on B lymphocytes in Cd22a lupus-prone mice affects ligand binding
46. Differential Activation of Anti-Erythrocyte and Anti-DNA Autoreactive B Lymphocytes by the Yaa Mutation
47. Differential Role of Three Major New Zealand Black-Derived Loci Linked with Yaa-Induced Murine Lupus Nephritis
48. Selective expansion of a monocyte subset expressing the CD11c dendritic cell marker in theYaa model of systemic lupus erythematosus
49. Th1/Th2 cells in inflammatory disease states: therapeutic implications
50. Targeting IL-15 Receptor-Bearing Cells with an Antagonist Mutant IL-15/Fc Protein Prevents Disease Development and Progression in Murine Collagen-Induced Arthritis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.